发明名称 |
IL-33 antagonists and uses thereof |
摘要 |
The present invention provides interleukin-33 (IL-33) antagonists comprising one or more IL-33-binding domains and one or more multimerizing domains and methods of using the same. According to certain embodiments of the invention, the IL-33-binding domains can comprise an IL-33-binding portion of an ST2 protein and/or an extracellular portion of an IL-1RAcP protein. The IL-33 antagonists of the invention are useful for the treatment of diseases and disorders associated with IL-33 signaling and/or IL-33 cellular expression, such as infectious diseases, inflammatory diseases, allergic diseases and fibrotic diseases. |
申请公布号 |
US9637535(B2) |
申请公布日期 |
2017.05.02 |
申请号 |
US201414210599 |
申请日期 |
2014.03.14 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
Murphy Andrew J.;Papadopoulos Nicholas J.;Orengo Jamie |
分类号 |
C07K14/715;A61K45/06;A61K39/395;A61K38/00 |
主分类号 |
C07K14/715 |
代理机构 |
Alston & Bird LLP |
代理人 |
Alston & Bird LLP ;Mallon Veronica |
主权项 |
1. An interleukin-33 (IL-33) antagonist comprising a first IL-33 binding domain (D1), a second IL-33 binding domain (D2), and a multimerizing domain (M), wherein D1, or D2, or both D1 and D2 are attached to the multimerizing domain (M), wherein D1 comprises an extracellular portion of a suppression of tumorigenicity (ST2) protein, D2 comprises an extracellular portion of an interleukin-1 receptor accessory protein (IL-1RAcP), and M comprises an Fc portion of an immunoglobulin. |
地址 |
Tarrytown NY US |